277 related articles for article (PubMed ID: 22083179)
1. [Infusion reaction and anaphylaxis].
Yoshida K; Shiono M; Ishioka C
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1753-7. PubMed ID: 22083179
[TBL] [Abstract][Full Text] [Related]
2. Management and preparedness for infusion and hypersensitivity reactions.
Lenz HJ
Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
[TBL] [Abstract][Full Text] [Related]
3. Infusion reactions: diagnosis, assessment, and management.
Vogel WH
Clin J Oncol Nurs; 2010 Apr; 14(2):E10-21. PubMed ID: 20350882
[TBL] [Abstract][Full Text] [Related]
4. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
[TBL] [Abstract][Full Text] [Related]
5. [Allergic reaction and anaphylaxis].
Natsume M; Honda T; Seki N
Nihon Rinsho; 2015 Feb; 73 Suppl 2():514-8. PubMed ID: 25831814
[No Abstract] [Full Text] [Related]
6. Desensitization for hypersensitivity reactions to medications.
del Carmen Sancho M; Breslow R; Sloane D; Castells M
Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
[TBL] [Abstract][Full Text] [Related]
7. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
Broome CB; Schiff RI; Friedman HS
Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847
[TBL] [Abstract][Full Text] [Related]
8. [Infusion reactions].
Sato K; Kohgo Y
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1671-4. PubMed ID: 18931569
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and biotherapy-induced hypersensitivity reactions.
Van Gerpen R
J Infus Nurs; 2009; 32(3):157-65. PubMed ID: 19444023
[TBL] [Abstract][Full Text] [Related]
10. How to manage hypersensitivity reactions to biological agents?
Barbaud A; Granel F; Waton J; Poreaux C
Eur J Dermatol; 2011; 21(5):667-74. PubMed ID: 21742594
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
Lee C; Gianos M; Klaustermeyer WB
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reactions to antineoplastic agents: an overview.
Syrigou E; Makrilia N; Koti I; Saif MW; Syrigos KN
Anticancer Drugs; 2009 Jan; 20(1):1-6. PubMed ID: 19342995
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
Castells M; Sancho-Serra Mdel C; Simarro M
Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054
[TBL] [Abstract][Full Text] [Related]
14. Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
Maindrault-Goebel F; André T; Tournigand C; Louvet C; Perez-Staub N; Zeghib N; De Gramont A
Eur J Cancer; 2005 Oct; 41(15):2262-7. PubMed ID: 16154353
[TBL] [Abstract][Full Text] [Related]
15. Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses.
Baldo BA; Pagani M
Immunol Allergy Clin North Am; 2014 Aug; 34(3):565-96, viii. PubMed ID: 25017678
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab-associated infusion reactions: pathology and management.
Patel DD; Goldberg RM
Oncology (Williston Park); 2006 Oct; 20(11):1373-82; discussion 1382, 1392-4, 1397. PubMed ID: 17112000
[TBL] [Abstract][Full Text] [Related]
17. A chemotherapy, hypersensitivity and anaphylaxis protocol.
Macartney G; Hopkins S; George-Chayka D; Jolicoeur L;
Can Oncol Nurs J; 2005; 15(3):198-200. PubMed ID: 16261816
[No Abstract] [Full Text] [Related]
18. Acute reactions to chemotherapy agents.
de Lemos ML
J Oncol Pharm Pract; 2006 Sep; 12(3):127-9. PubMed ID: 17022867
[TBL] [Abstract][Full Text] [Related]
19. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.
Chung CH
Oncologist; 2008 Jun; 13(6):725-32. PubMed ID: 18586928
[TBL] [Abstract][Full Text] [Related]
20. The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.
Pagani M
Med Clin North Am; 2010 Jul; 94(4):835-52, xiii. PubMed ID: 20609866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
